Use of palivizumab for prevention of hospitalization as a result of respiratory syncytial virus in infants with cystic fibrosis

被引：32
|
作者：
Speer, Michael E. [1 ]
Fernandes, Caraciolo J. [1 ]
Boron, Marnie [2 ]
Groothuis, Jessie R. [2 ]
机构：
[1] Baylor Coll Med, Dept Pediat, Sect Neonatol, Houston, TX 77030 USA
[2] Medimmune Inc, Gaithersburg, MD 20878 USA
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2008年 / 27卷 / 06期
关键词：
cystic fibrosis; RSV; palivizumab; hospitalization;
D O I：
10.1097/INF.0b013e3181673c15
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The Palivizumab Outcomes Registry collected data on 19,548 high-risk infants who received >= 1 dose of palivizumab and followed prospectively from 2000 through 2004. Ninety-one children with cystic fibrosis (CF) were identified who received palivizumab off label. None of the infants with CF who received prophylaxis was hospitalized as a result of respiratory syncytial virus lower respiratory tract infection. Evaluations of palivizumab use in infants with CF could be warranted.
引用
下载
收藏
页码：559 / 561
页数：3
相关论文
共 50 条
  • [41] Effectiveness of Palivizumab Against Respiratory Syncytial Virus Hospitalization Among Preterm Infants in a Setting With Year-Round Circulation
    Yeo, Kee Thai
    Yung, Chee Fu
    Khoo, Poh Choo
    Saffari, Seyed Ehsan
    Sng, Jane Swee Peng
    How, Mee See
    Quek, Bin Huey
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (02): : 279 - 287
  • [42] Comparison of the timing of initial prophylactic palivizumab dosing on hospitalization of neonates for respiratory syncytial virus
    Ohler, Kirsten H.
    Pham, Jennifer T.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (15) : 1342 - 1346
  • [43] Human respiratory syncytial virus and other viral infections in infants receiving palivizumab
    Boivin, Guy
    Caouette, Georges
    Frenette, Line
    Carbonneau, Julie
    Ouakki, Manale
    De Serres, Gaston
    JOURNAL OF CLINICAL VIROLOGY, 2008, 42 (01) : 52 - 57
  • [44] Utilization Management Opportunities for Palivizumab for Prophylaxis of Respiratory Syncytial Virus Complications in Infants
    Curtiss, Frederic R.
    Fairman, Kathleen A.
    JOURNAL OF MANAGED CARE PHARMACY, 2010, 16 (01): : 59 - 66
  • [45] Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV)
    Geskey, Joseph M.
    Thomas, Neal J.
    Brummel, Gretchen L.
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (01): : 33 - 43
  • [46] Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants
    Pedraz, C
    Carbonell-Estrany, X
    Figueras-Aloy, J
    Quero, J
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (09) : 823 - 827
  • [47] Palivizumab prophylaxis of respiratory syncytial virus infection in high-risk infants
    Vogel, AM
    Lennon, DR
    Broadbent, R
    Byrnes, CA
    Grimwood, K
    Mildenhall, L
    Richardson, V
    Rowley, S
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2002, 38 (06) : 550 - 554
  • [48] Respiratory syncytial virus: Early immunoprophylaxis in NICU preterm infants using palivizumab
    Bonaparte, J
    Wu, SY
    Pyati, S
    PEDIATRIC RESEARCH, 2003, 53 (04) : 311A - 311A
  • [49] PALIVIZUMAB FOR PROPHYLAXIS AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN CHILDREN WITH CYSTIC FIBROSIS: RESULTS OF A COCHRANE SYSTEMATIC REVIEW
    Saldanha, I.
    Mckoy, N. A.
    Robinson, K. A.
    PEDIATRIC PULMONOLOGY, 2010, : 331 - 331
  • [50] Prevention of syncytial respiratory virus infection with palivizumab: descriptive and comparative analysis after 12 years of use
    Narbona-Lopez, Eduardo
    Uberos, Jose
    Checa-Ros, Ana
    Rodriguez-Belmonte, Rocio
    Munoz-Hoyos, Antonio
    MINERVA PEDIATRICA, 2018, 70 (06) : 513 - 518
12345